[1] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重症肝病与人工肝学组.肝衰竭诊治指南.中华临床感染病志,2012,5:321-327.
[2] 郭丽娜.糖皮质激素的合理应用.临床合理用药,2015,8:96-97.
[3] Fujiwara K , Yasui S , Yonemitsu Y,et al.Efficacy of high-dose corticosteroid in the early stage of viral acute liver failure.Hepatol Res,2014,44:491-501.
[4] 刘明,张绪清,毛青.慢加急性肝衰竭前期的概念及预警模型.临床肝脏病杂志,2012,28:732-734.
[5] 余子琪,陈建勇.合理应用糖皮质激素治疗乙型肝炎病毒相关肝衰竭.国际消化病杂志,2017,37:366-368.
[6] Wong VW, Wong GL, Yiu KK, et al.Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B.Journal of Hepatology,2011,54:236-242.
[7] Tsubota A , Arase Y , Suzuki Y.Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B.J Gastroenterol Hepatol,2005,20 : 426-432.
[8] Fujiwara K, Yasui S, Okitsu K, et al.The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.J Gastroenterol, 2010,45:1255-1262.
[9] Li J, Wu J, Liu HX, et al.Early bilirubin response in acute-on-chronic hepatitis B liver failure patients treated with corticoste-roids predicates a lower 3-month mortality.Int J Clin exp Med, 2016,9: 10364-10373.
[10] Zhang XQ,Jiang L,You JP,et al.Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure.Hepatol Res,2011,41:46-53.
[11] Fujiwara K, Yasui S, Yonemitsu Y, et al.Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure.J Hepatobiliary Pancreat Sci, 2016,23:212-219.
[12] Yasui S, Fujiwara K, Haga Y,et al.Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure AND analysis in a Japanese center.J Hepatobiliary Pancreat Sci, 2016,23:756-762.
[13] Fujiwara K, Hida S, Yasui S, et al.Corticosteroid might reduce serum levels of pro-inflammatory cytokines in fulminant hepatitis AND A case series.Hepatology Research,2018,48:106-112.
[14] 朱跃科,贾琳,李娟,等.甲泼尼龙治疗对慢性乙型肝炎重症化趋势患者外周血树突细胞的影响与临床意义.中华临床感染病杂志,2016,9:433-438.
[15] 孟庆华.糖皮质激素治疗肝衰竭的时机把握.临床肝胆病杂志,2017,33:1683-1686.
[16] 聂青和.肝衰竭综合治疗进展.实用肝脏病杂志,2013,16: 17-19.
[17] 李林芳,吴春晓,杨晴.糖皮质激素治疗乙型肝炎早期肝衰竭的疗效观察.右江民族医学院学报,2016,38:274-276.
[18] Kotoh K, Enjoji M,Nakamuta M ,et al.Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure.World J Gastroenterol ,2006,12:6678-6682.
[19] Zhao B, Xie GJ, Li RF,et al.Dexamethasone protects normal human liver cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand by upregulating the expression of P-glycoproteins.Mol Med Rep,2015,12:8093-8100.
[20] 张野,聂青和.糖皮质激素治疗肝衰竭及高胆红素血症患者的临床研究及安全性评价.胃肠病学和肝病学杂志,2016,25:510-512.
[21] 张辉艳,张绪清.糖皮质激素治疗慢加急性肝衰竭前期的疗效预测模型与路线图.胃肠病学和肝病学杂志.2016,25:495-498.
[22] 汪萌,聂青和.不同糖皮质激素治疗措施治疗重型肝炎肝衰竭生存率及有效率对比: 网状荟萃分析.胃肠病学和肝病学杂志,2016,25:499-507.
[23] 国家卫生和计划生育委员会.糖皮质激素的应用范围和注意事项.中国社区医师,2014,30:5-7.
[24] Fujiwara K, Yokosuka O, Kojima H,et al.Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B. World J Gastroenterol ,2005,11:1109-1114.
[25] Fujiwara K, Yasui S, Yonemitsu Y,et al.Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B.J Gastroenterol ,2008,43: 711-719.
[26] Zhao J , Zhang JY , Yu HW, et al.Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapy.Cell Mol Immunol,2012,9:417-422. |
